Bogaert G A, Kogan B A, Mevorach R A, Wong J, Gluckman G R, Fineman J R, Heymann M A
Department of Urology, University of California School of Medicine, San Francisco 94143-0738, USA.
J Urol. 1996 Aug;156(2 Pt 2):847-53. doi: 10.1097/00005392-199608001-00085.
Endothelin-1 is known to be a potent vasoconstrictor. We investigated the effects and mechanisms of action of endothelin-1 and its receptors in regulating renal vascular tone in the fetal lamb.
We observed the in vivo effects of endothelin-1, an endothelin-b receptor agonist (4-alanine-endothelin-1), endothelin-a receptor antagonists (BQ-610 and BQ-123), and the inhibition of prostaglandin and nitric oxide synthesis on the response of the renal circulation to endothelin-1 in a chronic preparation in third trimester fetal lambs.
After injection of 250 ng./kg. endothelin-1 into the descending aorta proximal to the renal arteries in 8 fetal animals, renal blood flow increased (4.4 +/- 0.7 ml. per minute per kg., p < 0.001 versus vehicle), as did mean arterial blood pressure (3.0 +/- 0.3 mm. Hg,p < 0.001 versus vehicle). Calculated renal vascular resistance decreased (-1.1 +/- 0.2 mm. Hg per minute per kg./ml., p < 0.001 versus vehicle). After injection of 1,725 ng./kg. 4-alanine-endothelin-1 in 5 animals renal blood flow increased (3.8 +/- 0.4 ml. per minute per kg., p < 0.05 versus vehicle) and mean arterial blood pressure was unchanged (1.6 +/- 1.7 mm. Hg). Calculated renal vascular resistance decreased (-0.8 +/- 0.2 mm. Hg per minute per kg./ml., p < 0.05 versus vehicle). After injection of 0.5 mg./kg. BQ-610 in 6 animals renal blood flow increased (2.3 +/- 0.7 ml. per minute per kg., p < 0.05) and mean arterial blood pressure decreased (-2.7 +/- 0.3 mm. Hg, p < 0.05 versus vehicle). Calculated renal vascular resistance decreased but this difference was not statistically significant (-0.7 +/- 0.3 mm. Hg per minute per kg./ml., p < 0.07). A dose of 1 mg./kg. BQ-123 in 2 animals decreased renal vascular resistance markedly. Infusion of a prostaglandin synthesis inhibitor (1 mg./kg. per minute meclofenamic acid) did not alter the decrease in renal vascular resistance after endothelin-1 (-0.7 +/- 0.4 mm. Hg per minute per kg./ml). In contrast, during infusion of a nitric oxide synthesis inhibitor (1.5 mg./kg. per minute N-omega-nitro-L-arginine) endothelin-1 increased renal vascular resistance (1.2 +/- 0.2 mm. Hg per minute per kg./ml., p < 0.001).
Endothelin-1 is a vasodilator in the fetal renal circulation, which acts primarily via endothelin-b receptors. Ongoing activity of endothelin-a receptors contributes to renal vascular tone in fetal lambs. The vasodilatory effects of endothelin-1 in the fetal lamb renal circulation are mediated via the nitric oxide system and not via prostanoids.
已知内皮素 -1 是一种强效血管收缩剂。我们研究了内皮素 -1 及其受体在调节胎羊肾血管张力方面的作用及作用机制。
我们在孕晚期胎羊的慢性实验准备中,观察了内皮素 -1、内皮素 -B 受体激动剂(4 - 丙氨酸 - 内皮素 -1)、内皮素 -A 受体拮抗剂(BQ - 610 和 BQ - 123)的体内作用,以及前列腺素和一氧化氮合成抑制对肾循环对内皮素 -1 反应的影响。
向 8 只胎羊肾动脉近端的降主动脉注射 250 ng/kg 内皮素 -1 后,肾血流量增加(4.4±0.7 ml/分钟/千克,与溶媒组相比,p<0.001),平均动脉血压也升高(3.0±0.3 mmHg,与溶媒组相比,p<0.001)。计算得出的肾血管阻力降低(-1.1±0.2 mmHg/分钟/千克/毫升,与溶媒组相比,p<0.001)。向 5 只动物注射 1725 ng/kg 4 - 丙氨酸 - 内皮素 -1 后,肾血流量增加(3.8±0.4 ml/分钟/千克,与溶媒组相比,p<0.05),平均动脉血压无变化(1.6±1.7 mmHg)。计算得出的肾血管阻力降低(-0.8±0.2 mmHg/分钟/千克/毫升,与溶媒组相比,p<0.05)。向 6 只动物注射 0.5 mg/kg BQ - 610 后,肾血流量增加(2.3±0.7 ml/分钟/千克,p<0.05),平均动脉血压降低(-2.7±0.3 mmHg,与溶媒组相比,p<0.05)。计算得出的肾血管阻力降低,但差异无统计学意义(-0.7±0.3 mmHg/分钟/千克/毫升,p<0.07)。向 2 只动物注射 1 mg/kg BQ - 123 可显著降低肾血管阻力。输注前列腺素合成抑制剂(1 mg/kg/分钟甲氯芬那酸)未改变内皮素 -1 注射后肾血管阻力的降低情况(-0.7±0.4 mmHg/分钟/千克/毫升)。相反,在输注一氧化氮合成抑制剂(1.5 mg/kg/分钟 N - ω - 硝基 - L - 精氨酸)期间,内皮素 -1 增加了肾血管阻力(1.2±0.2 mmHg/分钟/千克/毫升,p<0.001)。
内皮素 -1 在胎羊肾循环中是一种血管舒张剂,主要通过内皮素 -B 受体起作用。内皮素 -A 受体的持续活性有助于胎羊的肾血管张力。内皮素 -1 在胎羊肾循环中的血管舒张作用是通过一氧化氮系统而非前列腺素介导的。